Topical and Nasal AOD-9604 Topical and nasal forms appear in marketing, but the FDA review found no published human exposure data for transdermal or intranasal AOD-9604
According to the National Institutes of Health Office of Dietary Supplements, an estimated 6% of adults under 60 in the United States are B12 deficient, with the prevalence rising to nearly 20% in adults over 60
Vascular issues Though rare, overuse of therapeutic B12 may lead to vascular events: Clots in deep veins Swelling in the legs Risk of pulmonary complications in sensitive groups Tabular View for Quick Recap You should report symptoms early to stop things from getting worse
As a result, you can get more B12 with injections than with oral supplementseven if you take higher oral doses
Research shows that using advanced analytical techniques allows for the separation, identification and quantification of each compounds components to verify that SLU-PP-332 and 5-Amino-1MQ meet research purity and potency specifications
Exact figures vary by study design and should be read from the individual publications